We provide novel bounds on average treatment effects (on the treated) that are valid under an unconfoundedness assumption. Our bounds are designed to be robust in challenging situations, for example, when the conditioning variables take on a large number of different values in the observed sample, or when the overlap condition is violated. This robustness is achieved by only using limited "pooling" of information across observations. Namely, the bounds are constructed as sample averages over functions of the observed outcomes such that the contribution of each outcome only depends on the treatment status of a limited number of observations. No information pooling across observations leads to so-called "Manski bounds", while unlimited information pooling leads to standard inverse propensity score weighting. We explore the intermediate range between these two extremes and provide corresponding inference methods. We show in Monte Carlo experiments and through two empirical application that our bounds are indeed robust and informative in practice.
Stochastic Causal Programming for Bounding Treatment Effects
Helmholtz AI(亥姆霍兹人工智能研究所);Helmholtz Munich(亥姆霍兹慕尼黑中心);Technical University Munich(慕尼黑工业大学);University College London(伦敦大学学院);King’s College London(伦敦国王学院)
Collaborative Indirect Treatment Comparisons with Multiple Distributed Single-arm Trials
University of Pennsylvania(宾夕法尼亚大学);Pfizer Inc.(辉瑞公司);Division of Biostatistics and Health Data Science, University of Minnesota Twin Cities(明尼苏达双城大学生物统计与健康数据科学系);School of Mathematical Sciences, Peking University(北京大学数学科学学院)
Toward Efficient Estimation of Regional Treatment Effects in Multi-Regional Clinical Trials
Gilead Sciences(吉利德科学);State Key Laboratory of Mathematical Sciences, Academy of Mathematics and Systems Science, Chinese Academy of Sciences(中国科学院数学与系统科学研究院数学与应用数学国家重点实验室);Biostatistics and Bioinformatics Branch, Division of Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(美国国立卫生研究院儿童与健康人类发展研究所尤妮丝·肯尼迪·施莱弗国家儿童健康与人类发展研究所人口健康研究处生物统计与生物信息学分支)
A Class of Algorithms for General Instrumental Variable Models
Max Planck Institute for Intelligent Systems(马克斯·普朗克智能系统研究所);University of Cambridge(剑桥大学);Helmholtz AI(亥姆霍兹人工智能中心);University College London(伦敦大学学院);The Alan Turing Institute(艾伦·图灵研究所)
State policy heterogeneity analyses: considerations and proposals
RAND Corporation(兰德公司);Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University(约翰斯·霍普金斯大学彭博公共卫生学院生物统计系);Rutgers Institute for Health, Health Care Policy, and Aging Research, Rutgers University(罗格斯大学健康、医疗政策和老龄化研究所)
Analyzing Within-Subject Experiments: Identification, Testing, and Sensitivity
National School of Development, Peking University(北京大学国家发展研究院);Governance Lab, Massachusetts Institute of Technology(麻省理工学院治理实验室);Center for Statistical Science, Peking University(北京大学统计科学中心)
Targeted Data Fusion for Region-Specific Survival Effects in the AMP HIV Prevention Trials
North Carolina State University(北卡罗来纳州立大学);Duke Clinical Research Institute(杜克临床研究所);University of Pennsylvania(宾夕法尼亚大学);Duke University School of Medicine(杜克大学医学院);Fred Hutch Cancer Center(弗雷德·哈钦癌症中心);Brown University(布朗大学)